PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ceutica & Chemie Healthcare Pvt. Ltd ., Bangalore, India.\', \'Department of Internal Medicine, King George\'s Medical University , Lucknow, India.\', \'Division of Pathology, Indian Veterinary Research Institute (IVRI) , Bareilly, India.\', \'Department of Centre for Advanced Research (CFAR), Faculty of Medicine, King George\'s Medical University (KGMU) , Lucknow, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/21645515.2020.1808410
?:hasPublicationType
?:journal
  • Human vaccines & immunotherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 32962524
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19: benefits and risks of passive immunotherapeutics.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32962524>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32962524>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all